1. Home
  2. BRNS vs KNRX Comparison

BRNS vs KNRX Comparison

Compare BRNS & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

HOLD

Current Price

$0.69

Market Cap

55.9M

Sector

Health Care

ML Signal

HOLD

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.80

Market Cap

49.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BRNS
KNRX
Founded
2016
2009
Country
United Kingdom
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
55.9M
49.9M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
BRNS
KNRX
Price
$0.69
$1.80
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
101.8K
13.8K
Earning Date
11-07-2025
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,820,365.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1766.46
24.00
52 Week Low
$0.64
$1.25
52 Week High
$2.92
$4.00

Technical Indicators

Market Signals
Indicator
BRNS
KNRX
Relative Strength Index (RSI) 33.40 N/A
Support Level $0.66 N/A
Resistance Level $0.78 N/A
Average True Range (ATR) 0.07 0.00
MACD 0.02 0.00
Stochastic Oscillator 7.88 0.00

Price Performance

Historical Comparison
BRNS
KNRX

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

Share on Social Networks: